effect treatments kejriwal trailer recover nobel half cytokine hospital afp responses 2b interferon placebo coronavirus defences research activate cold roundup meet associated drugs delta activity steroid alpha hydroxychloroquine wntβcatenin omicron

Articles for Interferon, search results for drugs

New class of antiviral drugs against Covid infection developed
9 months, 2 weeks ago

New class of antiviral drugs against Covid infection developed

Hindustan Times  

In a study published in the journal Nature, the researchers show that SARS-CoV-2 — the virus that causes COVID-19 — activates a pathway in cells that stops the production of peroxisomes and interferon, both key parts of the normal immune response. HT Image The team from the University of Alberta in Canada successfully tested the new class of antiviral drugs …

Drugs Interferon Production Interferon
Used to treat Hepatitis C, here's how Zydus' repurposed drug Virafin can aid recovery of Covid patients
3 years, 8 months ago

Used to treat Hepatitis C, here's how Zydus' repurposed drug Virafin can aid recovery of Covid patients

India Today  

Zydus Cadila's Pegylated Interferon alpha-2b drug, 'Virafin', has received Emergency Use Approval from DCGI, the Drugs Controller General of India. Pharma giant Zydus Cadila says its anti-viral drug Virafin can not only reduce the need for medical oxygen but also improve recovery time among Covid-19 patients. Earlier launched as PegiHep, the drug was being used to treat Hepatitis C. A …

India Viral Covid Drug Treat Hepatitis C Interferon
Zydus Cadila Seeks DCGI Nod for Use of Hepatitis Drug for Covid-19 Treatment
3 years, 8 months ago

Zydus Cadila Seeks DCGI Nod for Use of Hepatitis Drug for Covid-19 Treatment

News 18  

Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India for additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19. Phase-III clinical trials with Pegylated Interferon Alpha 2b, which company sells under the brand name 'PegiHep' has shown promising results in treating COVID-19, Zydus Cadila said …

India Drug Dcgi Alpha Interferon Zydus Cadila Cadila
The disease-resistant patients exposing Covid-19's weak spots
3 years, 10 months ago

The disease-resistant patients exposing Covid-19's weak spots

BBC  

The disease-resistant patients exposing Covid-19's weak spots Ying Tang/Getty Images There are some people whose bodies have reacted differently to Covid-19 compared to the rest of the population Some people are unusually resilient to the coronavirus, so scientists are now searching their genes and blood in the hope of finding the pandemic's Achilles' heel. "The idea is to try and …

Disease Patients Blood New York Covid Zhang Getty Images
A vaccine might not be enough – we need Covid-19 treatments that work
3 years, 11 months ago

A vaccine might not be enough – we need Covid-19 treatments that work

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. Put that together with the fickle …

Vaccines Need Virus Britain Vaccine Treatments Interferon Beta
Zydus Cadila gets DCGI nod for Phase 3 trial of repurposed drug to treat Covid-19
4 years ago

Zydus Cadila gets DCGI nod for Phase 3 trial of repurposed drug to treat Covid-19

India Today  

Gujarat-based drug manufacturer Zydus Cadila today said it has received approval from the Drugs Controller General of India to conduct Phase 3 clinical trials on its re-purposed drug that it hopes to use for Covid-19 treatment. The drug, Pegylated Interferon alpha-2b, 'PegiHepTM', is an approved drug that been in use since 2001 and is now being re-purposed to treat Covid-19 …

India Trial Trials Patients Drug Phase Clinical
Remdesivir useless in covid fight: WHO
4 years, 2 months ago

Remdesivir useless in covid fight: WHO

Live Mint  

A World Health Organization trial of Gilead Sciences Inc.’s remdesivir, the antiviral drug used to treat US President Donald Trump, showed little or no effect on the survival rates of covid patients, a result that is in variance with the trial reports of the drugmaker. The WHO trial, which also studied the effect of hydroxychloroquine, a combination of HIV drugs …

Trial Gilead Remdesivir Lopinavir
WHO Solidarity Trials find Remdesivir, HCQ, HIV drug, interferon ineffective in treating COVID-19
4 years, 2 months ago

WHO Solidarity Trials find Remdesivir, HCQ, HIV drug, interferon ineffective in treating COVID-19

Firstpost  

The WHO’s Solidarity Therapeutics Trial was conducted in 11,266 adult patients in 405 hospitals across more than 30 countries. The World Health Organization’s Solidarity trial is the world’s largest ongoing randomized control trial of potential COVID-19 therapeutics. Based on data collected from the trial, the WHO has released an interim report of patients’ responses to repurposed drugs for COVID-19 treatment. …

Solidarity Trial Drugs Trials Patients Drug Reuters